PY-MAA-VAL-CIT-PAB-MMAE
99%
- Product Code: 223188
CAS:
2247398-68-9
| Molecular Weight: | 1446.79 g./mol | Molecular Formula: | C₇₂H₁₁₁N₁₃O₁₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in antibody-drug conjugates (ADCs) for targeted cancer therapy. The compound links monoclonal antibodies to potent cytotoxic agents, enabling selective delivery of the drug to tumor cells. Upon binding to the target antigen on cancer cells, the ADC is internalized and the linker-payload is released, triggering cell death. This construct improves therapeutic efficacy while minimizing damage to healthy tissues. Commonly applied in research and development of oncology treatments, particularly for solid tumors and hematological malignancies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | $811.01 |
+
-
|
| 5mg | 10-20 days | $2,216.47 |
+
-
|
PY-MAA-VAL-CIT-PAB-MMAE
Used in antibody-drug conjugates (ADCs) for targeted cancer therapy. The compound links monoclonal antibodies to potent cytotoxic agents, enabling selective delivery of the drug to tumor cells. Upon binding to the target antigen on cancer cells, the ADC is internalized and the linker-payload is released, triggering cell death. This construct improves therapeutic efficacy while minimizing damage to healthy tissues. Commonly applied in research and development of oncology treatments, particularly for solid tumors and hematological malignancies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :